A study by the researchers shows reduction to muscle fat and double weight loss with a vegetarian diet compared with a low-calorie diabetic diet (diet as per the recommendations of the European Association for the Study of Diabetes EASD ) in type 2 diabetes (T2D) people. Researchers had conducted studies for 6 months duration among 74 type 2 diabetes (T2D) individuals with either a vegetarian diet or with a conventional low-calorie diabetic diet. Calorie intake in both the groups was reduced by 500 calories to the levels between 1,500 to 1,800 calories per day.
During the first three months or during the first half of the study, individuals following vegetarian diet had lost an average 14 pounds of weight and individuals following low-calorie diet had lost an average 7 pounds weight. During the second half of the study, the participants followed the similar diet but did an hour duration aerobic exercises for three times in a week. They gained muscle mass during that period and registered little weight loss. Researchers studied participants tissue that stores fat (adipose tissue) with the help of magnetic resonance imaging. Results shows
Earlier studies show higher muscle fat is associated with higher insulin resistance among type 2 diabetes (T2D) patients. Functioning of insulin in type 2 diabetes (T2D) individuals improves as the muscle fat reduces. Authors of the study say the vegetarian diet not only reduces weight or obesity but also address the cause of the disease. Following table describes the food items consumed in both types of diets in a day.
Lead author of the study was Dr. Hana Kahleova MD, PhD, director of clinical research, Physicians Committee, Washington DC, United States. The study findings were published in the Journal of the American College of Nutrition. Title of the article was "The Effect of a Vegetarian vs Conventional Hypocaloric Diabetic Diet on Thigh Adipose Tissue Distribution in Subjects with Type 2 Diabetes: A Randomized Study".
A small study involving 21 type 1 diabetes (T1D) individuals (T1D), done by the researchers at the University of California, San Diego shows improvement to the blood glucose or sugar levels of type 1 diabetes (T1D) patients with a single dose of a glucagon-blocking drug. The study also shows makable reduction to the insulin requirements of the type 1 diabetes (T1D) patients with a human monoclonal antibody and an investigational glucagon-blocking drug called REMD-477. The study results show
Lead author of the study was Jeremy Pettus, MD, assistant professor of medicine, endocrinology department, the University of California, San Diego, United States. The study findings were presented at the American Diabetes Association, 77th Scientific Sessions, San Diego Convention Center, United States. Title of the presentation was "Glucagon-Blocking Drug Reduces Need for Insulin and Improves Blood Glucose Levels for Patients with Type 1 Diabetes".
The Diabetes News Chronicle does not provide medical advice, diagnosis or treatment. Information in Diabetes News Chronicle is to support and not to replace medical advice given by the surgeon or physician or doctor. Published article is not a medical advice by the OWNER of "Diabetes News Chronicle" website or by the AUTHOR of the article.
Published by Jammi Vasista, Chennai, India.